Bupropion for Adults with Attention Deficit Hyperactivity Disorder
Overview
Overview
Journal
Curr Psychiatry Rep
Publisher
Current Science
Specialty
Psychiatry
Date
2002 Aug 15
PMID
12174849
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Faraone S, Biederman J, Spencer T, Wilens T, Seidman L, Mick E
. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry. 2000; 48(1):9-20.
DOI: 10.1016/s0006-3223(00)00889-1.
View
2.
Wilens T, Biederman J, Prince J, Spencer T, Faraone S, Warburton R
. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996; 153(9):1147-53.
DOI: 10.1176/ajp.153.9.1147.
View
3.
Biederman J, Wilens T, Mick E, Spencer T, Faraone S
. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999; 104(2):e20.
DOI: 10.1542/peds.104.2.e20.
View
4.
Spencer T, Wilens T, Biederman J, Faraone S, Ablon J, Lapey K
. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1995; 52(6):434-43.
DOI: 10.1001/archpsyc.1995.03950180020004.
View
5.
Conners C, Casat C, Gualtieri C, Weller E, Reader M, Reiss A
. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry. 1996; 35(10):1314-21.
DOI: 10.1097/00004583-199610000-00018.
View